Try our corporate solution for free!
(212) 419-8286

Top global pharmaceutical companies based on pharma revenue 2019

This statistic depicts the top 10 global pharmaceutical companies based on pharmaceutical revenue in 2019. In that year, Swiss corporation Novartis generated some 47.5billion U.S. dollars of pure pharmaceutical revenue.

Top global pharmaceutical companies

The top pharmaceutical companies when based exclusively on revenue with pharmaceutical products are Pfizer, Novartis, and Roche, as of 2019. The companies generated 51.2 billion U.S. dollars, 47.5 billion U.S. dollars, and 50 billion U.S. dollars, respectively, in that year. In the last years, Swiss company Novartis maintained its top 3 ranking. Novartis is a multinational company based in Basel, Switzerland. The company was established in 1996 through the merger of Swiss pharmaceutical companies, Ciba-Geigy and Sandoz Laboratories. One of Novartis' segment consists of over-the-counter drugs such as Excedrin. Excedrin garnered some 78 million U.S. dollars in revenue in the year ended mid-June 2019 in the United States. This is a drug normally marketed as a headache pain reliever and sold in the form of a tablet or caplet.

From the United Sates, Johnson & Johnson was one of the largest biotechnology and pharmaceutical companies as of 2019, generating some 42 billion U.S. dollars in total pharmaceuticals revenue. Johnson & Johnson’s revenue from the company’s top three drugs accounted for around a third of the company’s total pharmaceutical revenues. In 2018, the U.S. pharma industry spent some 62 billion U.S. dollars within the country on pharmaceutical research and development and over 17 billion U.S. dollars abroad.

Leading 10 global pharmaceutical companies based on pharma revenue in 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

March 2020



Survey time period


Supplementary notes

This statistic includes only revenues from pharmaceutical segments.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.